FESK.COMYour global study desk
Email us
Home › Scholar › Em Van Loi Doan
COMPILEDopen profilenot managed by this scholar
E

Em Van Loi Doan

Researcher Profile 5/10
This is my profile

Information

Featured publications

The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 202327 citations
The Lancet Regional Health - Western Pacific · 2024 · DOI
Safety and Efficacy of Tattoo Removal Using a Dual‐Wavelength 1064/532‐nm Picosecond Laser in Patients With Fitzpatrick Skin Type III and IV8 citations
Lasers in Surgery and Medicine · 2020 · DOI
Simultaneous versus sequential fractional CO2 laser and subcision combination for management of post‐acne atrophic scars: A split‐face comparative study3 citations
Journal of Cosmetic Dermatology · 2024 · DOI
Diverse clinical manifestations of acquired vulvar lymphangioma: a report of five cases in Vietnamese women
Dermatology Reports · 2024 · DOI
Concomitant Sexually Transmitted Infections in Patients With Anal Warts: A Single‐Center, Cross‐Sectional Study in Ho Chi Minh City, Vietnam
Health Science Reports · 2026 · DOI

About the field of Medicine and Pharmacy

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field:

These figures count profiles currently in this directory, not nationwide statistics.

The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗

Suggest / Claim this profile

  
Profile aggregated from public sources. We respect scholars' rights to edit and remove information — all requests are processed promptly.
Em Van Loi DoanHCMC Hospital of Dermato Venereology
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.